Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement

Michael J. Barry, Wanda K. Nicholson, Michael Silverstein, David Chelmow, Tumaini Rucker Coker, Esa M. Davis, Katrina E. Donahue, Carlos Roberto Jaén, Li Li, Gbenga Ogedegbe, Goutham Rao, John M. Ruiz, James Stevermer, Joel Tsevat, Sandra Millon Underwood

Producción científica: Review articlerevisión exhaustiva

14 Citas (Scopus)

Resumen

Importance: Familial hypercholesterolemia and multifactorial dyslipidemia are 2 conditions that cause abnormally high lipid levels in children, which can lead to premature cardiovascular events (eg, myocardial infarction and stroke) and death in adulthood. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for lipid disorders in asymptomatic children and adolescents. Population: Asymptomatic children and adolescents 20 years or younger without a known diagnosis of a lipid disorder. Evidence Assessment: The USPSTF concludes that the current evidence is insufficient and the balance of benefits and harms for screening for lipid disorders in asymptomatic children and adolescents 20 years or younger cannot be determined. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. (I statement).

Idioma originalEnglish (US)
Páginas (desde-hasta)253-260
Número de páginas8
PublicaciónJAMA
Volumen330
N.º3
DOI
EstadoPublished - jul 18 2023

ASJC Scopus subject areas

  • General Medicine

Huella

Profundice en los temas de investigación de 'Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement'. En conjunto forman una huella única.

Citar esto